Why Choose P3 Research?

Quality
  • Dedicated clinical research facilities - no conflict of interest
  • Highly experienced team deliver quality results
  • GCP compliant
  • Internal SOP system and QA procedures
  • Successful audits by major clients
Safety
  • Patient safety comes first
  • Staff fully trained in emergency procedures
  • Facilities located within short distance of hospitals
  • Internal safety assessment performed for all studies
  • Specialists consulted as appropriate
Efficiency
  • We understand the client's need for studies to be conducted in a timely manner
  • All queries are dealt with promptly
  • Prompt and easy access to Investigators
  • Excellent recruitment history
  • Established database of clinical trial volunteers
Experience
  • Staff are highly experienced in many therapeutic areas
  • Company established in 1998
  • Over 100 trials since 2005
  • Extensive database of volunteers
  • Experienced in specialist respiratory research
  • Clients include GSK, Johnson & Johnson, Boehringer Ingelheim, Takeda, Altana, Almirall,  Resistentia, Merck Sharpe & Dohme, Novartis, Pearl Therapeutics, Alder Biopharmaceuticals, Cerimon Pharmaceuticals, Cephalon Inc., Covance, Novotech, PPD, Parexel, Eisai Ltd., Quintiles, Daiichi Sankyo Inc., Millennium Pharmaceuticals, Hollister Inc., Barrier Therapeutics, Intercell AG, Replidyne Inc., Celgene, Pfizer, Aradigm Corporation, Chemocentryx, Janssen-Cilag, Gilead Sciences Inc., Icon Clinical Research,  Centocor Ortho Biotech Inc., Solvay Biologicals BV, Abbott, Hoffmann-La Roche, Eli Lilly.  
Location
  • Opposite seasons to Northern Hemisphere - allows seasonal research to continue year round
  • High ethical standards similar to Europe and Australia
  • Excellent communication systems
  • Facilities located in good population centres, within easy reach of International air transport
  Bookmark this page in your web browserwww.p3research.co.nz - Why choose P3 Research?CartNo Items in your Cart